e-learning
resources
Virtual 2020
Pre-Congress Content
Mechanism or pathways of chronic lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
hsCRP is associated with 10-year mortality in COPD.
E. Lagrange (Umeå, Sweden), U. Nilsson (Umeå, Sweden), C. Stridsman (Umeå, Sweden), H. Backman (Umeå, Sweden), L. Hedman (Umeå, Sweden), A. Lindberg (Umeå, Sweden), A. Blomberg (Umeå, Sweden)
Source:
Virtual Congress 2020 – Mechanism or pathways of chronic lung diseases
Session:
Mechanism or pathways of chronic lung diseases
Session type:
E-poster session
Number:
2075
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Lagrange (Umeå, Sweden), U. Nilsson (Umeå, Sweden), C. Stridsman (Umeå, Sweden), H. Backman (Umeå, Sweden), L. Hedman (Umeå, Sweden), A. Lindberg (Umeå, Sweden), A. Blomberg (Umeå, Sweden). hsCRP is associated with 10-year mortality in COPD.. 2075
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Definition and history of sarcoidosis
Evidence of early abnormal airways’ inflammation in children with type 1 diabetes
Related content which might interest you:
Triglycerides are associated with five-year mortality in COPD patients
Source: Annual Congress 2012 - COPD comorbidities I
Year: 2012
No impact of statins on time to first COPD exacerbation or all-cause mortality
Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data
Year: 2021
Copeptin predicts all-cause mortality in stable COPD: An analysis of the COSYCONET study
Source: Virtual Congress 2020 – Diagnosis and management of COPD
Year: 2020
The impact on risk-factor analysis of different mortality outcomes in COPD patients
Source: Eur Respir J 2008; 32: 629-636
Year: 2008
COPD the unseen factor causing increased morbidity and mortality among IHD patients
Source: Annual Congress 2009 - COPD case-finding and management in primary care
Year: 2009
Desmosine is a predictor of long-term cardiovascular mortality in bronchiectasis
Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases
Year: 2020
Accelerated FEV
1
decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients
Source: Eur Respir J, 57 (3) 2000918; 10.1183/13993003.00918-2020
Year: 2021
Plasma microfibrillar-associated protein 4 is not prognostic of emphysema progression but is associated with cardiovascular disease history and mortality in COPD patients
Source: ERJ Open Res, 5 (2) 00021-2019; 10.1183/23120541.00021-2019
Year: 2019
Factors associated with one-year mortality in hospitalized patients with exacerbation of bronchiectasis.
Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria
Year: 2020
Circulating desmosine levels do not predict emphysema progression but are associated with cardiovascular risk and mortality in COPD
Source: Eur Respir J 2016; 47:1365-1373
Year: 2016
COPD phenotypes and 5-years mortality risk prediction: PALOMB Cohort
Source: Virtual Congress 2020 – Comorbidities/multimorbidites and mortality in patients with chronic lung diseases
Year: 2020
Risk charts of five-year mortality in COPD patients
Source: International Congress 2019 – COPD: epidemiology and spirometry
Year: 2019
In hospitalized COPD exacerbation (COPDE) patients a 30-day readmission is associated with a progressive increased risk of mortality
Source: International Congress 2015 – COPD: interesting notes
Year: 2015
Glitazones are associated with reduced risk of COPD exacerbations and mortality among patients with diabetes
Source: Annual Congress 2011 - COPD: burden of disease, imaging and management
Year: 2011
Prior cardiovascular disease increases long-term mortality in COPD patients with pneumonia
Source: Eur Respir J 2014; 43: 36-42
Year: 2004
Tiotropium and the risk of cardiovascular events and all-cause mortality
Source: Annual Congress 2010 - Comorbidities and disease management in primary care
Year: 2010
Changes in physical activity and all-cause mortality in COPD
Source: Eur Respir J 2014; 44: 1199-1209
Year: 2014
Predictors of mortality in COPD
Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects
Year: 2008
Predictors of mortality in COPD
Source: Annual Congress 2009 - Prognosis and comorbidities in COPD
Year: 2009
10-year follow-up of hospitalised COPD-patients: Comorbidities, mortality and cause of death
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept